SLC1A5 and glioma: Correspondingly, lncRNA-XIST knockdown in glioma promotes ROS production and apoptosis and inhibits cell proliferation in SLC1A5/miR-137 dependent fashion, which can be reversed by cell supplementation with N-acetyl-L-Cysteine (NAC), a scavenger of ROS [44].